MichaelWangMD
Pediatric Hematology & Oncology • Aurora, COProfessor, Pediatrics, University of Colorado School of Medicine
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13199 E Montview Blvd.
Suite 100
Aurora, CO 80045Phone+1 303-724-0365Fax+1 303-724-0078
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 2000 - 2004
University of Utah HealthResidency, Pediatrics, 1996 - 1999
University of Rochester School of Medicine and DentistryClass of 1996
Certifications & Licensure
CO State Medical License 2000 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD) Start of enrollment: 2019 Apr 01
Roles: Principal Investigator
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) Start of enrollment: 2017 Dec 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- Retrospective chart review of GI bleeding in people with von Willebrand disease.Jonathan C Roberts, Miguel A Escobar, Suchitra Acharya, Nina X Hwang, Michael Wang
Haemophilia. 2024-07-01 - 3 citationsThree-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.Bella Madan, Margareth C Ozelo, Priyanka Raheja, Emily Symington, Doris V Quon
Journal of Thrombosis and Haemostasis. 2024-07-01 - 1 citationsSafety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B.Richard Lemons, Michael Wang, Julie Curtin, Lynda Mae Lepatan, Christoph Male
TH Open. 2024-01-01
Press Mentions
- Ibrutinib Extends Survival for Older Mantle Cell Lymphoma PatientsJune 8th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
